Chen Jianfeng, Chen Haiyan, Liu Ru, He Jun, Song Lin, Bian Qian, Xu Lichun, Zhou Jianwei, Xiao Hang, Dai Guidong, Chang Hebron C, Wang Xinru
Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 210029, China.
Reprod Toxicol. 2005 Jul-Aug;20(2):195-202. doi: 10.1016/j.reprotox.2005.01.013.
In this study, primary serum-free cultured rat granulosa cells (rGCs) were used as a cellular model to investigate the effects of fenvalerate on progesterone production. Various concentrations (0, 1, 5, 25, 125 and 625 microM) of fenvalerate were added to the cell cultures for 24 h. rGCs were stimulated by compounds such as follicle-stimulating hormone (FSH), 8-bromo-cAMP or 22(R)-hydroxycholesterol (22R-HC). Progesterone production and intracellular cAMP content were measured in control and treated groups. Expression of P450 side chain cleavage enzyme (P450scc) and steroidogenic acute regulatory protein (StAR) were monitored by real-time PCR and Western blotting. Results showed that fenvalerate inhibited basal progesterone production in rGCs in the absence of stimulators. This inhibition was stronger in the presence of FSH and was not fully reversed by 8-bromo-cAMP or 22R-HC. The increase of cAMP content, stimulated by FSH, was inhibited by fenvalerate implicating that the intracellular cAMP-dependent signal pathway was involved. Fenvalerate reduced mRNA and protein expression of P450scc. These results suggested that multi-site inhibition of progesterone production by fenvalerate including a cAMP-dependent protein kinase pathway and reduction on P450scc gene expression and/or its enzymatic activity in rGCs.
在本研究中,原代无血清培养的大鼠颗粒细胞(rGCs)被用作细胞模型,以研究氰戊菊酯对孕酮生成的影响。将不同浓度(0、1、5、25、125和625微摩尔)的氰戊菊酯添加到细胞培养物中24小时。rGCs用促卵泡激素(FSH)、8-溴-cAMP或22(R)-羟基胆固醇(22R-HC)等化合物刺激。在对照组和处理组中测量孕酮生成和细胞内cAMP含量。通过实时PCR和蛋白质印迹法监测细胞色素P450侧链裂解酶(P450scc)和类固醇生成急性调节蛋白(StAR)的表达。结果表明,在没有刺激剂的情况下,氰戊菊酯抑制rGCs中的基础孕酮生成。在FSH存在的情况下,这种抑制作用更强,并且8-溴-cAMP或22R-HC不能完全逆转。FSH刺激引起的cAMP含量增加被氰戊菊酯抑制,这表明细胞内cAMP依赖性信号通路参与其中。氰戊菊酯降低了P450scc的mRNA和蛋白质表达。这些结果表明,氰戊菊酯对孕酮生成的多部位抑制包括cAMP依赖性蛋白激酶途径以及rGCs中P450scc基因表达和/或其酶活性的降低。